Escient Pharmaceuticals Funding: $238M Raised, Series C
Escient Pharmaceuticals is based in San Diego. It has raised $238M in total funding. Latest round: Series C.
Escient Pharmaceuticals funding overview
Escient Pharmaceuticals is based in San Diego. Escient Pharmaceuticals has raised $238M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in November 2022. The round record for Escient Pharmaceuticals runs through 2022; nothing later has been disclosed. Investors on record include Abingworth, Forge Life Science Partners, NEA, 5AM Ventures, Access Biotechnology, Atlas Venture and 13 others. 19 distinct backers are named across the disclosed rounds.
Escient Pharmaceuticals at a glance
Total raised
$238M
Latest round
Series C
Latest round date
November 2022
Headquarters
San Diego
Notable investors
Abingworth, Forge Life Science Partners, NEA, 5AM Ventures, Access Biotechnology, Atlas Venture, Carol Gallagher, Robert Garland
Frequently asked about Escient Pharmaceuticals funding
How much has Escient Pharmaceuticals raised?
Escient Pharmaceuticals has raised $238M in total disclosed funding across the rounds on record.
Who has invested in Escient Pharmaceuticals?
Abingworth, Forge Life Science Partners, NEA, 5AM Ventures, Access Biotechnology, Atlas Venture are named among the investors backing Escient Pharmaceuticals.
What was the latest Escient Pharmaceuticals funding round?
The most recent disclosed round is a Series C, announced in November 2022.
Where is Escient Pharmaceuticals based?
Escient Pharmaceuticals is based in San Diego.
When did Escient Pharmaceuticals last raise?
The last disclosed Escient Pharmaceuticals round closed in November 2022 at Series C.
Totals shown for Escient Pharmaceuticals aggregate every disclosed round on file. To see how that compares, browse the companies in San Diego and the investors behind them below.
